The Effect of Multivitamins, Minerals, and Q10 on Precancerous Lesions of the Cervix

Objectives: Invasive cervical cancer is one of the most fatal genital cancers of women which can be detected by having Pap smear in precancerous stage. Various approaches can be taken for treating or preventing the progress of these precancerous lesions. The aim of this study was to investigate the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of women's health and reproduction sciences 2021-10, Vol.9 (4), p.280-283
Hauptverfasser: Modarres Gilani, Mitra, Mosavi, Azam Sadat, Akhavan, Setare, Zamani, Mehrangiz, Mohsenpour, Mohammad Ali, Mohsenpour, Fatemeh, Pir Dehghan, Azar, Farhadi, Danial, Torkzaban, Fazezeh
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives: Invasive cervical cancer is one of the most fatal genital cancers of women which can be detected by having Pap smear in precancerous stage. Various approaches can be taken for treating or preventing the progress of these precancerous lesions. The aim of this study was to investigate the cytopathological and colposcopic response of precancerous lesions to multivitamin, mineral (multi-mineral), and coenzyme Q10 supplements. Materials and Methods: The present randomized clinical trial was conducted on 120 participants with clinical complaints or abnormal Pap smear test results. The intervention and control groups received supplemental and placebo treatments, respectively, for 3 months after a primarily Pap smear test. The Pap smear test was also performed after the treatment and patients with abnormal results were screened by colposcopy. Data were analyzed by SPSS software and P-value less than 0.05 was considered significant. Results: The percentage of participants in the intervention and control groups were 40% and 28.3% in the age range of 20-29, 26.7% and 41.7% in the age range of 30–39, and finally 33.3% and 30% over 40 years of age, respectively (P=0.19). The percentage of normalization in Pap smear test result was 83.3% and 53.3% in the intervention and control groups, respectively (P
ISSN:2330-4456
2330-4456
DOI:10.15296/ijwhr.2021.51